PHATPhathom Pharmaceuticals, Inc.
$5.72-58% 1Y
$5.72
$5.7252 weeks$18.08
Latest close: a new 52-week lowOct 23, 2026what changed →
Is the price fair?
What PHAT's price assumes
Phathom Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.79× revenue.
3.79
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 3.71
EV / sales
Details›
- EV / EBIToperating margin −17%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 3.71
- Market capitalisation80.9 million shares, counted Jul 27, 2026
- $463M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
Ranks #161 of 194 by RyuScore